Scientists have designed novel synthetic ligands activating the Notch signaling pathway via AI-driven protein engineering, enhancing T-cell development and function. Published in Cell, this advancement holds promising applications for improving clinical immunotherapies where precise modulation of T-cell activity is critical. The work showcases how computational protein design can accelerate the creation of biologics that better control immune responses in cancer and other diseases.